eNewsletters

    FCDI Notebook February 2021Issue highlights:

    • News:
      • Missed the iForum™ 2021? View the Sessions Online
      • iCell Products in SARS-CoV-2 and COVID-19 Research: See Data on ACE-2 Expression and Cardiotoxicity Modeling
    • Events:
      • See upcoming poster presentations at AD/PD and SOT 2021
    • Publications:
      • iPSC-Derived Hepatocytes Generated from NASH Donors Provide a Valuable Platform for Disease Modeling and Drug Discovery
      • Electrophysiological Phenotype Characterization of Human iPSC-Derived Neuronal Cell Lines by Means of High-Density Microelectrode Arrays
      • Pluripotent Stem Cell-Derived Hepatocytes Phenotypic Screening Reveals Small Molecules Targeting the CDK2/4-C/EBPα/DGAT2 Pathway Preventing ER-Stress Induced Lipid Accumulation
    • Applications:
      • See the New Application Protocol: Measuring Cardiac Contractility with the Nanion FLEXcyte 96 System

    Issue highlights:

    • Upcoming Events:
      • Register now for the iForum™ 2021 Virtual User Group and see full agenda of speakers and talk titles
      • See the abstracts two poster presentations for SOT2021
    • New Publications:
      • Analysis of Reproducibility and Robustness of a Human Microfluidic Four-Cell Liver Acinus Microphysiology System (LAMPS)
      • A 3D Microfluidic Liver Model for High Throughput Compound Toxicity Screening in the OrganoPlate®

    Issue highlights:

    • Upcoming Events:
      • Register now for the iForum™ 2021 Virtual User Group and see the speakers confirmed for this event.
      • See the abstracts for a Alzheimer's disease modeling poster to be presented at SfN 2021
    • New Publications:
      • Soluble Factors Released by Dedifferentiated Fat Cells Reduce the Functional Activity of iPS Cell-Derived Cardiomyocytes
      • Rapid Hazard Characterization of Environmental Chemicals Using a Compendium of Human Cell Lines from Different Organs
    • Read how Century Therapeutics is addressing challenges in the manufacturing of iPSC-derived cell therapies through the use of their technology platform and partnership with FCDI.

    Issue highlights:

    • Events on demand:
      • See the presentation from the 2020 Nanion User Group Meeting
      • See the FCDI webinar presentation of a new iCell® Cardiomyocytes2 11713 line and a new protocol for automated arrhythmia detection
      • See the MaxWell Biosystems presentation on HD-MEA
    • New Publications:
      • Reengineering an Antiarrhythmic Drug Using Patient hiPSC Cardiomyocytes to Improve Therapeutic Potential and Reduce Toxicity
      • Microdose Lithium Reduces Cellular Senescence in Human Astrocytes - A Potential Pharmacotherapy for COVID-19?
      • Mitomycin‐C Treatment during Differentiation of Induced Pluripotent Stem Cell‐derived Dopamine Neurons Reduces Proliferation without Compromising Survival or Function In Vivo

    Issue highlights:

    • Upcoming events:
      • A webinar on high-density microelectrode arrays and their application in Parkinson’s and ALS modeling
      • A webinar on the new iCell® Cardiomyocytes2 launch, and automated detection and classification of arrhythmias
    • FCDI and Axxam form a strategic alliance to provide an integrated platform for advanced drug discovery.
    • New publications highlighting:
      • iCell products to facilitate T cell immunotherapeutics efficacy and safety testing
      • A brain-on-chip model for Parkinson’s disease modeling and therapeutics discovery
      • Electrophysiological characterization and comparison of iCell neuronal cells by HD-MEA